2026 NPPES data Oral & Maxillofacial Surgery (D.M.D.) NPI 1255306866 MD, DDS, FACS
Verify on CMS →

LANCE GRENEVICKI, MD, DDS, FACS

Oral & Maxillofacial Surgery (D.M.D.) in WEST MELBOURNE, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
964
Medicare Part D claims · 301 beneficiaries · Oral & Maxillofacial Surgery (D.M.D.) avg: 324

What the federal data shows

LANCE GRENEVICKI, MD, DDS, FACS filed 964 Medicare Part D claims in 2023 as a Oral & Maxillofacial Surgery (D.M.D.) in WEST MELBOURNE, Florida.

964
Part D claims, 2023

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LANCE GRENEVICKI, MD, DDS, FACS's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

964 Top 25% higher than 75% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

LANCE GRENEVICKI, MD, DDS, FACS practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about LANCE GRENEVICKI, MD, DDS, FACS?

Quality data not reported

NPI registry status

Active

Issued 02/18/2006

NPI 1255306866

Primary specialty

Oral & Maxillofacial Surgery (D.M.D.)

Niche

1,112 US NPIs in this specialty

Medicare Part D claims

964 198% vs specialty avg

2023 prescription claims

Specialty avg: 324

Specialty distribution in Florida

How Oral & Maxillofacial Surgery (D.M.D.) compares to other specialties among Florida providers

Florida providers

Oral & Maxillofacial Surgery (D.M.D.) share within Florida

1. Oral & Maxillofacial Surgery (D.M.D.)42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oral & Maxillofacial Surgery (D.M.D.) share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Oral & Maxillofacial Surgery (D.M.D.) (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oral & Maxillofacial Surgery (D.M.D.) ABMS/AOA estimate

Est. board-certified rate (Oral & Maxillofacial Surgery (D.M.D.)) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oral & Maxillofacial Surgery (D.M.D.)) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LANCE GRENEVICKI, MD, DDS, FACS appears in the CMS NPPES registry as a Oral & Maxillofacial Surgery (D.M.D.) provider holding MD, DDS, FACS credentials at 1093 S WICKHAM RD, WEST MELBOURNE, FL, 32904, with a listed phone of (321) 674-3900. NPI 1255306866 was issued on 02/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GRENEVICKI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 964 prescription claims written by this provider, covering 301 Medicare beneficiaries and totaling roughly $11K in drug spend, with an opioid prescribing rate of 24.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oral & Maxillofacial Surgery (D.M.D.) is a narrow specialty nationwide, with 1,112 enrolled providers across 52 states and an average of 324 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1093 S WICKHAM RD
WEST MELBOURNE, FL 32904

Provider Details

NPI 1255306866
Specialty Oral & Maxillofacial Surgery (D.M.D.)
Credentials MD, DDS, FACS
Gender Male
NPI Issued 02/18/2006

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to LANCE GRENEVICKI, MD, DDS, FACS. To verify LANCE GRENEVICKI, MD, DDS, FACS's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

964
Total Claims
$11K
Total Drug Cost
301
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
979
Total Day Supply
11,708
Generic Drug Cost
$11K
Opioid Claims
239 (24.8% rate)
Antibiotic Claims
326

Patient Demographics

Average Patient Age
73.4 years
Avg HCC Risk Score
1.41
Gender Split
59% female / 41% male
Age Distribution
<65: 22, 65-74: 155, 75-84: 98, 85+: 26

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LANCE GRENEVICKI, MD, DDS, FACS prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Chlorhexidine Gluconate
240
Amoxicillin
213
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
113
Acetaminophen-Codeine
Acetaminophen With Codeine
106
Dexamethasone
71
Clindamycin Hcl
45
Nystatin
45
Doxycycline Hyclate
23
Cephalexin
19
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oral & Maxillofacial Surgery (D.M.D.) Overview

How LANCE GRENEVICKI, MD, DDS, FACS fits within the Oral & Maxillofacial Surgery (D.M.D.) landscape nationally.

1,112
Oral & Maxillofacial Surgery (D.M.D.) Providers in US
52
States with Oral & Maxillofacial Surgery (D.M.D.)
324
Avg Claims per Provider

LANCE GRENEVICKI, MD, DDS, FACS's 964 claims are above the specialty average of 324.

Nearby Oral & Maxillofacial Surgery (D.M.D.) Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as GRENEVICKI.

Compare Oral & Maxillofacial Surgery (D.M.D.) nationally: see state-by-state distribution →

Frequently Asked Questions

What is LANCE GRENEVICKI, MD, DDS, FACS's specialty?
LANCE GRENEVICKI, MD, DDS, FACS specializes in Oral & Maxillofacial Surgery (D.M.D.) and practices in WEST MELBOURNE, Florida. Credentials: MD, DDS, FACS.
How much does LANCE GRENEVICKI, MD, DDS, FACS prescribe under Medicare Part D?
In 2023, LANCE GRENEVICKI, MD, DDS, FACS wrote 964 Medicare Part D claims totaling $11K in drug costs for 301 beneficiaries.
Where is LANCE GRENEVICKI, MD, DDS, FACS located?
LANCE GRENEVICKI, MD, DDS, FACS is located at 1093 S WICKHAM RD, WEST MELBOURNE, FL, 32904. Phone: (321) 674-3900.
What is LANCE GRENEVICKI, MD, DDS, FACS's NPI number?
LANCE GRENEVICKI, MD, DDS, FACS's National Provider Identifier (NPI) is 1255306866, issued on 02/18/2006.
Does LANCE GRENEVICKI, MD, DDS, FACS prescribe opioids?
Yes, LANCE GRENEVICKI, MD, DDS, FACS had 239 opioid claims in 2023 with an opioid prescribing rate of 24.8%.
How many Oral & Maxillofacial Surgery (D.M.D.) providers are there in the US?
There are 1,112 Oral & Maxillofacial Surgery (D.M.D.) providers across 52 states in the US. The average Oral & Maxillofacial Surgery (D.M.D.) provider writes 324 Medicare Part D claims per year.
What drugs does LANCE GRENEVICKI, MD, DDS, FACS prescribe most often?
Based on 2023 Medicare Part D data, LANCE GRENEVICKI, MD, DDS, FACS's most frequently prescribed drugs include Chlorhexidine Gluconate, Amoxicillin, Hydrocodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LANCE GRENEVICKI, MD, DDS, FACS accept Medicare?
LANCE GRENEVICKI, MD, DDS, FACS appears in CMS Medicare data with 964 Part D claims and 301 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LANCE GRENEVICKI, MD, DDS, FACS's credentials?
LANCE GRENEVICKI, MD, DDS, FACS's NPI is 1255306866 with credentials MD, DDS, FACS. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology